公司资料
Akero Therapeutics 股价、新闻与催化剂
- 股票代码:
- AKRO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 AKRO 的收盘价变动背景。
公司概览
业务概览
Akero Therapeutics is a metabolic-liver biotech focused on MASH and related liver-disease biology.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Akero sits in specialty biopharmaceuticals.
商业模式特征
Its model depends on liver-disease data, dose optimization, and the potential to build a differentiated metabolic franchise.
生物医药行业定位
Akero is one of the more closely watched MASH names because efficacy signals can move the stock sharply.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。